We would like to thank our exhibitors for sponsoring this meeting, which includes pharmaceutical companies, including AstraZeneca UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

4 CPD hours

Thursday, November 13, 2025
9:20 AM - 10:15 AM
Chair’s opening remarks followed by: Unravelling ILD: the hidden cause of breathlessness
  • What is interstitial lung disease and why early recognition matters 
  • How imaging, especially HRCT, supports accurate diagnosis 
  • The role of the MDT in managing patients with suspected or confirmed ILD 
Helena Beer Editor, Hospital Healthcare Europe, Hospital Pharmacy Europe , Cogora
Ravijyot Saggu Respiratory and Medicines Optimisation Pharmacist, UKCPA Respiratory Committee Chair, Clinical Member, NHSE Respiratory Clinical Reference Group
 
 
10:25 AM - 11:10 AM
Next-generation propellant: Leading the way with world-first innovations for COPD
  • Guidance on sustainability and reducing the carbon footprint of respiratory care
  • Establishing the impact of exacerbations on patients with COPD
  • Introducing the next-generation propellant
Prof. Manish Patel Consultant, General and Respiratory Medicine, University Hospital Wishaw, NHS Lanarkshire
Dr. Andrew Docherty Consultant Cardiologist, University Hospital Wishaw, NHS Lanarkshire
This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.
Next-generation propellant: Leading the way with world-first innovations for COPD
11:20 AM - 12:05 PM
Bronchiectasis uncovered: the overlooked cause of chronic cough and infection
  • How to identify key clinical and imaging features, including when to request a CT 
  • The impact of chronic infection, inflammation, and airway damage on patient outcomes 
  • Emerging treatments and long-term management strategies, including physiotherapy and targeted antibiotics 
Uta Hill Respiratory Consultant, Cambridge Centre of Lung Infection, Royal Papworth Hospital
 
 
12:15 PM - 1:00 PM
Antibiotic prescribing in respiratory infection: evidence, challenges, and opportunities
  • Insights from Imperial on prescribing behaviours and stewardship outcomes  
  • Discuss the challenges of diagnostic uncertainty and patient expectations in respiratory infection  
  • Explore opportunities for MDTs to lead culture change in antimicrobial stewardship
Prof. Suveer Singh Consultant in Respiratory and Critical Care Medicine, Royal Brompton, Chelsea & Westminster NHS Foundation Trusts
 
 
1:10 PM - 2:10 PM
Respiratory infections uncovered: Managing the surge
  • Understand how to measure and track the true scale of respiratory infections 
  • Learn how to identify patients suitable for safe discharge: criteria and community monitoring 
  • See how acute respiratory infection hubs can shift care into the community 
Prof. Matt Inada-Kim Consultant Acute Physician, Hampshire Hospitals NHS & University of Southampton, National Clinical Director, Infection Management and Antimicrobial Resistance, NHS England, UK Health Security Agency
 
 

If you want more information about our Clinical Excellence events:

Sign Up For Notifications

If you are interested in speaking at this event, please contact Pippa Baynham, Senior Conference Producer.

If you are interested in sponsoring a talk on the Agenda, or exhibiting at the event, please contact Ed Burkle, Sales Director.